JPRN-UMIN000043792已完成未知
Effect of suppressing the onset of cancer cachexia of Ninjin-yoei-To;Randomized Controlled Trial - Effect of suppressing the onset of cancer cachexia of Ninjin-yoei-To;Randomized Controlled Trials
Osaka Medical and Pharmaceutical College0 个研究点目标入组 0 人开始时间: 2021年4月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old(—)
- 性别
- All
入选标准
- 未提供
排除标准
- •1.Have active multiple cancers. 2. There is an active infectious disease. 3. Have clinically problematic diseases (collagen disease, renal failure, interstitial pneumonia, etc.) 4. It is judged that it is difficult to participate in the research because of mental illness or psychiatric symptoms. 5. In addition, the doctor in charge judges that it is inappropriate as the subject of this study.
研究者
相似试验
招募中
Unknown
A study of treatment of cancer cachexia and for reducing side effects of cancer treatment with conditioned mediumCancer cachexia, Side effects of cancer treatmentJPRN-jRCT1051220093Inami Norihito Norihito20
已完成
不适用
Prospective observational study of cancer-cachexia and its effect on chemotherapy in patients with previously-untreated advanced non-small cell lung cancer (NEJ050A)on-small cell lung cancerJPRN-UMIN000041813orth East Japan Study Group (NEJSG)186
招募中
不适用
The influence of sarcopenia and cancer cachexia on recovery of gastric and colonic surgerysarcopenia1001799010017998colorectal cancergastric cancerNL-OMON37020Medisch Universitair Ziekenhuis Maastricht90
招募中
不适用
A Study on the Effect of Cancer Treatment on the Cognitive Abilities of Cancer Patients Using Natural Language Processing Techniques for Spoken Languages -Monitoring cognitive function during the perioperative period and early after dischargeCancerJPRN-UMIN000039479Osaka International Cancer Insitute10
招募中
不适用
A Study on the Effect of Cancer Treatment on the Cognitive Abilities of Cancer Patients Using Natural Language Processing Techniques for Spoken LanguagesCancerJPRN-UMIN000033211Osaka International Cancer Insitute100
